Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Editorial: Biology and treatment of high-risk CLL.
Tausch E, Malcikova J, Riches JC, Edelmann J. Tausch E, et al. Among authors: malcikova j. Front Oncol. 2023 Feb 20;12:1109950. doi: 10.3389/fonc.2022.1109950. eCollection 2022. Front Oncol. 2023. PMID: 36891501 Free PMC article. No abstract available.
Innovation in the prognostication of chronic lymphocytic leukemia: how far beyond TP53 gene analysis can we go?
Pospisilova S, Sutton LA, Malcikova J, Tausch E, Rossi D, Montserrat E, Moreno C, Stamatopoulos K, Gaidano G, Rosenquist R, Ghia P; European Research Initiative on CLL (ERIC). Pospisilova S, et al. Among authors: malcikova j. Haematologica. 2016 Mar;101(3):263-5. doi: 10.3324/haematol.2015.139246. Haematologica. 2016. PMID: 26928246 Free PMC article. No abstract available.
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update.
Malcikova J, Pavlova S, Baliakas P, Chatzikonstantinou T, Tausch E, Catherwood M, Rossi D, Soussi T, Tichy B, Kater AP, Niemann CU, Davi F, Gaidano G, Stilgenbauer S, Rosenquist R, Stamatopoulos K, Ghia P, Pospisilova S. Malcikova J, et al. Leukemia. 2024 May 16. doi: 10.1038/s41375-024-02267-x. Online ahead of print. Leukemia. 2024. PMID: 38755420 Review.
Unveiling the dynamics and molecular landscape of a rare chronic lymphocytic leukemia subpopulation driving refractoriness: insights from single-cell RNA sequencing.
Kurucova T, Reblova K, Janovska P, Porc JP, Navrkalova V, Pavlova S, Malcikova J, Plevova K, Tichy B, Doubek M, Bryja V, Kotaskova J, Pospisilova S. Kurucova T, et al. Among authors: malcikova j. Mol Oncol. 2024 May 21. doi: 10.1002/1878-0261.13663. Online ahead of print. Mol Oncol. 2024. PMID: 38770541 Free article.
Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options.
Malcikova J, Pavlova S, Kunt Vonkova B, Radova L, Plevova K, Kotaskova J, Pal K, Dvorackova B, Zenatova M, Hynst J, Ondrouskova E, Panovska A, Brychtova Y, Zavacka K, Tichy B, Tom N, Mayer J, Doubek M, Pospisilova S. Malcikova J, et al. Blood. 2021 Dec 23;138(25):2670-2685. doi: 10.1182/blood.2020009530. Blood. 2021. PMID: 33945616 Free PMC article.
Complex analysis of the p53 tumor suppressor in lung carcinoma.
Smardova J, Liskova K, Ravcukova B, Malcikova J, Hausnerova J, Svitakova M, Hrabalkova R, Zlamalikova L, Stano-Kozubik K, Blahakova I, Speldova J, Jarkovsky J, Smarda J. Smardova J, et al. Among authors: malcikova j. Oncol Rep. 2016 Mar;35(3):1859-67. doi: 10.3892/or.2015.4533. Epub 2015 Dec 29. Oncol Rep. 2016. PMID: 26718964
56 results